Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
39S ribosomal protein L19, mitochondrial (MRPL19) is a nuclear-encoded mitochondrial ribosomal protein that is a component of the large 39S subunit of the mitochondrial ribosome. It plays a structural role in mitochondrial protein synthesis by participating in the formation and function of the mitoribosome, which is essential for translation of mitochondrial-encoded proteins involved in oxidative phosphorylation. Mammalian mitoribosomes are distinct in composition from prokaryotic ribosomes, with a higher protein-to-rRNA ratio and different subunit components. MRPL19 is associated with pathways related to mitochondrial translation and peptide chain elongation and is noted in genetic studies for possible links to neurodevelopmental disorders such as dyslexia[1][3][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 39S ribosomal protein L19, mitochondrial (MRPL19).